International Drug Safety Monitoring

International Drug Safety Monitoring

In the 1960s, following the Thalidomide Disaster, the World Health Organization (WHO) initiated the development of an international drug safety monitoring programme. The objectives of this WHO programme are to improve the quality and safety of pharmaceuticals, and to support public health programmes...

Full description

Bibliographic Details
Main Authors:	A. S. Kazakov, E. V. Shubnikova, M. A. Darmostukova, I. I. Snegireva, G. V. Kutekhova, K. E. Zatolochina, N. Yu. Velts, D. A. Kaperko, Yu. V. Olefir
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2019-09-01
Series:	Безопасность и риск фармакотерапии
Subjects:	drug safety monitoring adverse drug reactions pharmacovigilance world health organization vigibase
Online Access:	https://www.risksafety.ru/jour/article/view/151

Similar Items

Comparative Analysis of International Databases of Adverse Drug Reactions
by: A. S. Kazakov, et al.
Published: (2020-09-01)

Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic Treatment
by: E. Yu. Demchenkova, et al.
Published: (2021-03-01)

The Adverse Drug Reactions Registered During the Postmarketing Period
by: E. V. Shubnikova, et al.
Published: (2019-03-01)

Drug Safety for Children — International Monitoring Data for 50 Years
by: B. K. Romanov, et al.
Published: (2019-06-01)

Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacin
by: N. V. Molchan, et al.
Published: (2019-06-01)

Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase<sup>®</sup>)
by: Alemayehu Lelisa Duga, et al.
Published: (2023-04-01)

Drug Safety Monitoring—International Information
by: E. V. Shubnikova, et al.
Published: (2020-12-01)

Adverse Reactions of Drugs Containing Valeriana and Corvalol: Analysis of Spontaneous Reporting
by: S. L. Morokhina, et al.
Published: (2018-12-01)

Safety of Antibacterial and Antiprotozoal Medicinal Products
by: E. V. Shubnikova, et al.
Published: (2022-07-01)

Analysis of Hepatobiliary Disorder Reports Associated With the Use of Herbal Medicines in the Global Suspected ADR Database Vigibase
by: Florence van Hunsel, et al.
Published: (2019-11-01)

POST-MARKETING DRUG SAFETY RESEARCH: ANALYSIS OF RECOMMENDATIONS OF FOREIGN REGULATORS
by: E. V. Shubnikova, et al.
Published: (2018-09-01)

Monitoring Drug Safety Information - Recommendations of Foreign Regulatory Authorities
by: Elena V. Shubnikova, et al.
Published: (2020-03-01)

Signal Messages in Pediatric Practice
by: G. V. Kutekhova, et al.
Published: (2018-12-01)

Social media as a source of information on drug safety and how to extract it
by: I. I. Snegireva, et al.
Published: (2018-02-01)

Suspected cutaneous adverse drug reactions reported with traditional medicines: analysis of data for United Nations Asia region from WHO VigiBase
by: Manish J. Barvaliya, et al.
Published: (2023-05-01)

Modern approaches to collecting and reporting information on side effects
by: K. E. Zatolochina, et al.
Published: (2018-02-01)

ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
by: N. Yu. Velts, et al.
Published: (2018-09-01)

Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
by: Alan O. Vázquez-Alvarez, et al.
Published: (2017-12-01)

Safety of Remdesivir and Tocilizumab in COVID-19 Treatment
by: Alexandra A. Taube, et al.
Published: (2020-09-01)

Drug Safety Monitoring Information
by: E. V. Shubnikova, et al.
Published: (2021-07-01)

Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly
by: Mariana Sipos, et al.
Published: (2021-05-01)

Pharmacovigilance: Empowering healthcare professionals
by: Mugoša Snežana S., et al.
Published: (2015-01-01)

Comparing epidemiological methods in detecting drug safety signal in IRAN
by: G Shalviri, et al.
Published: (2005-12-01)

Reporting Antimicrobial-Related Adverse Drug Events in Jordan: An Analysis from the VigiBase Database
by: Nizar Mahmoud Mhaidat, et al.
Published: (2023-03-01)

Current Information on the Safety of Medicinal Products: Decisions of Foreign Regulatory Authorities
by: E. V. Shubnikova
Published: (2024-04-01)

EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE
by: M. N. Kostyleva, et al.
Published: (2015-03-01)

Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance
by: M. V. Zhuravleva, et al.
Published: (2019-09-01)

Pharmacovigilance Activities in Maulana Azad Medical College and Associated Hospitals: A Step towards Patient Safety
by: Vandana Roy, et al.
Published: (2023-01-01)

Recommendations on Informational Monitoring of the Safety and Efficacy of Medicinal Products in the Russian Federation as Part of Pharmacovigilance
by: K. S. Milchakov
Published: (2022-10-01)

Real-Life Active Surveillance of a Naphazoline/ Hypromellose Fixed Combination’s Safety Profile in Peruvian Population
by: Contreras-Salinas H, et al.
Published: (2021-10-01)

MONITORING OF DRUG SAFETY IN CLINICAL PRACTICE
by: N. V. Verlan, et al.
Published: (2017-02-01)

Clinical and pharmacological monitoring of drug safety in pediatrics
by: N. V. Verlan, et al.
Published: (2016-05-01)

Comparative evaluation of pharmacovigilance regulation of the United States, United Kingdom, Canada, India and the need for global harmonized practices
by: Mohit Hans, et al.
Published: (2018-01-01)

Expert Evaluation of Pharmacovigilance System Documents Included in the Registration Dossier
by: I. I. Snegireva, et al.
Published: (2020-12-01)

Safety of COVID-19 vaccines
by: B. K. Romanov
Published: (2022-12-01)

Knowledge and Perceptions of Adverse Events Following Immunization among Healthcare Professionals in Africa: A Case Study from Ghana
by: Peter Yamoah, et al.
Published: (2019-03-01)

DRUG SAFETY MONITORING SERVICE IN DEVELOPING ORGANIZATIONS / MANUFACTURERS OF DRUGS FOR VETERINARY USE
by: N. P. Biryukova, et al.
Published: (2019-09-01)

Safety Issues With the Use of Antimicrobials in Current Clinical Practice
by: Kuzmina A.V., et al.
Published: (2015-05-01)

Deriving meaningful insights from clinical trial and postmarketing safety data: Perspectives from India
by: Anand Harugeri, et al.
Published: (2017-01-01)

From Monitoring Drug Safety to Monitoring Patient Safety: A Strategic Focus for the Activity of Pharmacists
by: Francisco Batel Marques
Published: (2017-10-01)